Featured Research

from universities, journals, and other organizations

University of Florida Physicians Perform First "Mini" Bone Marrow Transplant

Date:
July 31, 1997
Source:
University Of Florida
Summary:
University of Florida physicians have performed a "mini" bone marrow transplant using much less intensive chemotherapy and no radiation.

By Melanie Fridl RossShands Public Relations

Related Articles


GAINESVILLE, Fla.---For what is thought to be the first time in Florida, University of Florida physicians have performed a "mini" bone marrow transplant using much less intensive chemotherapy and no radiation.

The experimental procedure, performed at Shands at UF and reported at only four other centers worldwide, could be an alternative for thousands of cancer patients too old or too ill to withstand conventional transplantation.

Larry Tucker, a 43-year-old Jacksonville resident fighting an aggressive form of lymphoma, was the recipient. Previous chemotherapy failed to keep the disease in check.

Doctors used potent drugs at half the usual doses to suppress his beleagured immune system, replacing it May 23 with powerful disease-fighting cells known as lymphocytes donated by his sister, said John Wingard, director of the bone marrow transplant program at Shands at UF. Tucker, who was discharged from the hospital June 20, will return as needed for repeated infusions of those cells. Physicians hope they will be the foundation for a new, more robust immune system.

"In the past, we have relied mostly on the "atom bomb" approach to treating cancer -- blasting the tumor with drugs and radiation treatment," Wingard said. "We are calling this a "kinder and gentler" transplant. With this new procedure, we are trying to exploit the new immune system of the donor to fight against the cancer.

"There are a number of patients who could potentially benefit from a bone marrow transplantation, but either because of their age or other illnesses they are excluded -- physicians fear aggressive regimens will be too tough and too toxic for them to endure," he added.

In Florida, the situation is complicated by an aging population. Up to now, older adults who contract cancer unresponsive to first-strike treatments have discovered they have few options. Meanwhile, diseases like leukemia primarily strike the elderly -- the average age at diagnosis is 64, Wingard said.

"Most patients who benefit from the current, most aggressive forms of treatment are very young," said Fred Weeks, a clinical fellow in medical oncology at UF's College of Medicine. "This is something we can offer the older patient with leukemia, particularly elderly patients with liver, heart or kidney disease who otherwise couldn't withstand high-dose chemotherapy. It's a very different way of thinking."

In Tucker's case, physicians feared he would not tolerate a traditional transplant because he also has hepatitis, a lung infection and impaired lung function from previous chemotherapy treatments. Early tests show the transplant successfully took. Time will tell whether it is effective against the cancer.

In recent years, physicians' understanding of the immune system has evolved.

"We used to think of cancer to be like an infectious disease entity where we had to kill off every last cell up front," Weeks said. "But what we've seen with this approach is that even if people have relapsed we might be able to bolster their immune system with donor cells and eventually get them into remission.

"The only way that could work, especially given the small number of lymphocytes from the donor -- about the amount in a pint of blood -- is that the immune system is a lot more powerful than we ever gave it credit."

The novel treatment also is offered at the M.D. Anderson Cancer Center in Houston, and medical centers in Singapore, Israel and Italy.

"We don't know ultimately if this is going to work; that's what we aim to find out," Wingard said. "But our study may show this to be very suitable for the large elderly population we have here in Florida."

----------------------------------------------------------------

Recent UF Health Science Center news releases also are available on the UF Health Science Center Communications home page. Point your browser to http://www.vpha.health.ufl.edu/hscc/index.html


Story Source:

The above story is based on materials provided by University Of Florida. Note: Materials may be edited for content and length.


Cite This Page:

University Of Florida. "University of Florida Physicians Perform First "Mini" Bone Marrow Transplant." ScienceDaily. ScienceDaily, 31 July 1997. <www.sciencedaily.com/releases/1997/07/970731081326.htm>.
University Of Florida. (1997, July 31). University of Florida Physicians Perform First "Mini" Bone Marrow Transplant. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/1997/07/970731081326.htm
University Of Florida. "University of Florida Physicians Perform First "Mini" Bone Marrow Transplant." ScienceDaily. www.sciencedaily.com/releases/1997/07/970731081326.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins